Dapagliflozin for acute heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a medicine called dapagliflozin (Farxiga) helps people with acute heart failure. You may qualify if you are in the hospital or ER for heart failure and need IV water pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have acute heart failure that requires hospital or emergency care.
- You must have high levels of BNP or NT-proBNP (heart strain markers) in your blood.
- You must be receiving IV water pills (diuretics) for your heart failure.
- You cannot have type 1 diabetes, a current infection in the urine or genitals, or serious kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if dapagliflozin or acetazolamide works better for people hospitalized with heart failure who have extra fluid in their body (congestion). The study will compare how well each medication helps remove fluid when used with standard IV diuretics.
This trial tests if dapagliflozin, a medication usually used for diabetes, can help people with acute heart failure recover heart function. If you are in the hospital for heart failure, this study will check if the drug improves how your heart squeezes.
This study tests how a medication called DAPA (an SGLT2 inhibitor) affects the body in people with heart failure (with or without type 2 diabetes), or in some people with type 2 diabetes only. It may help researchers understand who could benefit most and what changes happen in the heart, using specialized heart imaging.
This trial tests if dapagliflozin helps reduce fat around the heart in people with a type of heart failure where the heart pumps normally but is stiff. It might improve symptoms and overall health.
This trial tests whether giving gliflozin (a type of diabetes pill also used for heart failure) early in the emergency department helps older patients who are admitted for worsening heart failure. It aims to see if it can improve recovery and reduce the need for intensive treatment.
This trial tests whether adding dapagliflozin (a medication that helps protect the heart and kidneys) helps people with heart failure who are also on peritoneal dialysis. It may offer extra support for your heart and kidney health.
Hear when a new Acute Decompensated Heart Failure (ADHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.